BioSpace News Archive

Genetown

NeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell® for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine Conferences

NeuroMetrix, Inc. (Nasdaq: NURO) today reported that top-line results from a randomized controlled trial of Quell in patients with fibromyalgia will be presented at two upcoming pain medicine conferences.

June 9, 2021
·
4 min read
Biotech Beach

Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences - June 09, 2021

Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, announced that the Company will participate in upcoming investor and scientific conferences.

June 9, 2021
·
2 min read
BioMidwest

The Pancreatic Cancer Action Network Increases Biomarker-Driven Clinical Trial Matching Capabilities by nearly 300% with GenomOncology

GenomOncology announced today that the Pancreatic Cancer Action Network (PanCAN) has chosen to upgrade to GenomOncology’s Precision Decision to further enhance the free clinical trial matching services it offers to pancreatic cancer patients.

June 9, 2021
·
3 min read
Business

Celsion Appoints Christine A. Pellizzari to its Board of Directors

Celsion Corporation, a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, announced the appointment of Christine A. Pellizzari to the Celsion Board of Directors, effective June 8, 2021.

June 9, 2021
·
5 min read